We provide you with 20 years of free, institutional-grade data for GPCR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GPCR. Explore the full financial landscape of GPCR stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 1888886 | GPCR | 10-Q | Url |
| 2025-05-08 | 1888886 | GPCR | 10-Q | Url |
| 2025-02-27 | 1888886 | GPCR | 10-K | Url |
| 2024-11-13 | 1888886 | GPCR | 10-Q | Url |
| 2024-08-08 | 1888886 | GPCR | 10-Q | Url |
| 2024-06-03 | 1888886 | GPCR | S-1 | Url |
| 2024-05-09 | 1888886 | GPCR | 10-Q | Url |
| 2024-03-08 | 1888886 | GPCR | 10-K | Url |
| 2023-11-17 | 1888886 | GPCR | 10-Q | Url |
| 2023-11-17 | 1888886 | GPCR | S-1 | Url |
| 2023-08-10 | 1888886 | GPCR | 10-Q | Url |
| 2023-05-11 | 1888886 | GPCR | 10-Q | Url |
| 2023-03-30 | 1888886 | GPCR | 10-K | Url |
| 2023-01-12 | 1888886 | GPCR | S-1 | Url |
Structure Therapeutics Inc.(NASDAQ:GPCR) 
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 r...
Website: https://structuretx.com
Founded: 2016
IPO Price: $15 (Feb 03, 2023)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about GPCR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.